GMaP Region 3

Attending a virtual conference this spring?

If so, GMaP Region 3 would like to provide funding to help cover registration fees. Apply for funding through our travel award form (see Travel Scholarships below) today! For questions, please contact, Miria Kano.

Research Highlight

Dr. Joan Lewis-Wambi is an Associate Professor in the Cancer Biology Department at the University of Kansas Medical Center and a primary member of the University of Kansas Cancer Center. She has been a faculty member at KUMC since 2013. Dr. Lewis-Wambi's research focuses on understanding the pathobiology of inflammatory breast cancer (IBC) and to identify the molecular factors responsible for driving its aggressive phenotype especially in African American women. IBC is a very aggressive and lethal subtype of breast cancer that accounts for about 2-5% of all breast cancer cases diagnosed in the United States. IBC typically presents with rapid onset of painful primary skin changes and progresses to Stage IIIb/IV metastatic disease within six months. It has been shown to disproportionately affect African American women compared to other ethnic groups. Dr. Lewis-Wambi's laboratory has recently identified a novel molecular target, IFITM1, which appears to be highly expressed in IBC tumors and IBC cell lines from African American women compared to Caucasian American women. She has recently received a GMaP Region 3 pilot grant to study the biology and function of IFITM1 in IBC and to conduct a drug repurposing high throughput screen of FDA-approved drugs to selectively target IFITM1 expression in vivo using clinically relevant IBC mouse models.
  

Sign Up for Region 3 News

* indicates required




Interested in becoming a GMaP Region 3 member? Contact Miria Kano at 505-925-1115, or Contact Us.


From the NCI

Education  •   Members   •    About   •   Contact Us